DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Washington Court Hotel

2013 年 09 月 25 日 8:00 上午 - 2013 年 09 月 27 日 5:00 下午

525 New Jersey Avenue NW, Washington, DC 20001

DIA/FDA Oligonucleotide-based Therapeutics Conference

Session Chair(s)

Arthur A. Levin, PHD

Arthur A. Levin, PHD

Distinguished Scientist

Avidity Biosciences, United States

Haw-Jyh  Chiu, PHD

Haw-Jyh Chiu, PHD

Toxicologist, OMPT, Office of New Drugs, DHOT, CDER

FDA, United States

Speaker(s)

Bryan R. Cullen, PHD

Viruses and Micro RNAs

Bryan R. Cullen, PHD

Duke University Medical Center, United States

James B. Duke Professor, Dept. of Molecular Genetics & Microbiology

Carolyn  Coyne, PHD

The Placental-specific Chromosome 19 miRNA Cluster (C19MC) Exerts Antiviral Effects Against Diverse Viruses

Carolyn Coyne, PHD

University of Pittsburgh, United States

Assistant Professor, Dept. of Microbiology and Molecular Genetics

Gregory R. Heck, PHD

Using RNAi in Food Crops as Pesticides

Gregory R. Heck, PHD

Monsanto Company, United States

Weed Control Platform Lead

Tita  Ritsema

The Chance of a Lifetime: Developing Antisense Oligonucleotide-mediated RNA Modulation as a Cure for Cystic Fibrosis

Tita Ritsema

ProQR Therapeutics B.V., Netherlands

Program Manager

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。